Digital health—USA—Q&A guide
Digital health—USA—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Digital health—USA—Q&A guide
  • 1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?
  • 2. How would you describe the investment climate for digital health technologies in your jurisdiction, including any noteworthy challenges?
  • 3. What are the most notable recent deals in the digital health sector in your jurisdiction?
  • 4. What due diligence issues should investors address before acquiring a stake in digital health ventures?
  • 5. What financing structures are commonly used by digital health ventures in your jurisdiction? Are there any notable government financing or other support initiatives to promote development of the digital health space?
  • 6. What principal legislation governs the digital health sector in your jurisdiction?
  • 7. Which notable regulatory and enforcement bodies have jurisdiction over the digital health sector?
  • 8. What licensing and authorisation requirements and procedures apply to the provision of digital health products and services in your jurisdiction?
  • 9. Is there any notable ‘soft’ law or guidance governing digital health?
  • More...

This Practice Note contains a jurisdiction-specific Q&A guide to digital health in USA published as part of the Lexology Getting the Deal Through series by Law Business Research (published: February 2021).

Authors: Seyfarth Shaw LLP—Chris DeMeo; Sheryl Tatar Dacso; Tonya M. Esposito; Brian L. Michaelis ; John P. Tomaszewski

1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?

The US digital health market is one of the largest consumers of healthcare dollars in the world. The market is made up of companies involved in the development and deployment of technology, applications, health and individual services and user connectivity. These categories have experienced dramatic growth, most recently because of covid-19. The growth is in mobile health (mHealth), telemedicine, healthcare analytics and digital health devices. Companies recognised by Market Research Future as key players include iHealth Lab, General Electric, Cerner Corporation, BioTelemetry, McKesson, Cisco, Athenahealth, AT&T, EClinicalWorks, Allscripts and Qualcomm. In addition, research institutions such as TMC|X in Houston, Texas, through its business accelerator programme, and the University of California Los Angeles, through its Depression Grand Challenge, are partnering with industry to develop innovative treatment models. Transformational digital health strategies include innovations in telemedicine, AI and electronic health records geared to streamline access, improve quality, reduce error and lower costs. Increasing consumerism in healthcare delivery will

Popular documents